• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质-蛋白质相互作用抑制剂的抑制活性理论模型:用小分子靶向Menin-混合谱系白血病

Theoretical models of inhibitory activity for inhibitors of protein-protein interactions: targeting menin-mixed lineage leukemia with small molecules.

作者信息

Jedwabny Wiktoria, Kłossowski Szymon, Purohit Trupta, Cierpicki Tomasz, Grembecka Jolanta, Dyguda-Kazimierowicz Edyta

机构信息

Department of Chemistry , Wrocław University of Science and Technology , Wyb. Wyspiańskiego 27 , 50-370 Wrocław , Poland . Email:

Department of Pathology , University of Michigan , 1150 W. Medical Center Dr, MSRBI, Rm 4510D , Ann Arbor , MI 48109 , USA . Email:

出版信息

Medchemcomm. 2017 Dec 1;8(12):2216-2227. doi: 10.1039/c7md00170c. Epub 2017 Sep 12.

DOI:10.1039/c7md00170c
PMID:29456828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5774433/
Abstract

Development and binding affinity predictions of inhibitors targeting protein-protein interactions (PPI) still represent a major challenge in drug discovery efforts. This work reports application of a predictive non-empirical model of inhibitory activity for PPI inhibitors, exemplified here for small molecules targeting the menin-mixed lineage leukemia (MLL) interaction. Systematic analysis of menin-inhibitor complexes was performed, revealing the physical nature of these interactions. Notably, the non-empirical protein-ligand interaction energy comprising electrostatic multipole and approximate dispersion terms ((10)El,MTP + ) produced a remarkable correlation with experimentally measured inhibitory activities and enabled accurate activity prediction for new menin-MLL inhibitors. Importantly, this relatively simple and computationally affordable non-empirical interaction energy model outperformed binding affinity predictions derived from commonly used empirical scoring functions. This study demonstrates high relevance of the non-empirical model we developed for binding affinity prediction of inhibitors targeting protein-protein interactions that are difficult to predict using empirical scoring functions.

摘要

针对蛋白质-蛋白质相互作用(PPI)的抑制剂的开发和结合亲和力预测,仍然是药物研发工作中的一项重大挑战。本研究报告了一种用于PPI抑制剂抑制活性的预测性非经验模型的应用,此处以靶向Menin-混合谱系白血病(MLL)相互作用的小分子为例。对Menin-抑制剂复合物进行了系统分析,揭示了这些相互作用的物理本质。值得注意的是,包含静电多极和近似色散项的非经验蛋白质-配体相互作用能((10)El,MTP +)与实验测量的抑制活性具有显著相关性,并能够对新型Menin-MLL抑制剂的活性进行准确预测。重要的是,这种相对简单且计算成本较低的非经验相互作用能模型优于常用经验评分函数得出的结合亲和力预测。本研究表明,我们开发的非经验模型对于难以用经验评分函数预测的靶向蛋白质-蛋白质相互作用的抑制剂的结合亲和力预测具有高度相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b1/6072466/591be1c84d8e/c7md00170c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b1/6072466/7ad10310d75d/c7md00170c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b1/6072466/dbf8bbc4b87d/c7md00170c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b1/6072466/591be1c84d8e/c7md00170c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b1/6072466/7ad10310d75d/c7md00170c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b1/6072466/dbf8bbc4b87d/c7md00170c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b1/6072466/591be1c84d8e/c7md00170c-f3.jpg

相似文献

1
Theoretical models of inhibitory activity for inhibitors of protein-protein interactions: targeting menin-mixed lineage leukemia with small molecules.蛋白质-蛋白质相互作用抑制剂的抑制活性理论模型:用小分子靶向Menin-混合谱系白血病
Medchemcomm. 2017 Dec 1;8(12):2216-2227. doi: 10.1039/c7md00170c. Epub 2017 Sep 12.
2
Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein-Protein Interaction.基于结构的 M-89 发现:一种强效的 Menin-Mixed Lineage Leukemia(Menin-MLL)蛋白-蛋白相互作用抑制剂。
J Med Chem. 2019 Jul 11;62(13):6015-6034. doi: 10.1021/acs.jmedchem.9b00021. Epub 2019 Jun 22.
3
High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction.高亲和力的小分子抑制剂可模拟 menin-MLL 混合谱系白血病(MLL)相互作用的天然蛋白-蛋白相互作用。
J Med Chem. 2014 Feb 27;57(4):1543-56. doi: 10.1021/jm401868d. Epub 2014 Feb 6.
4
Discovery of two aminoglycoside antibiotics as inhibitors targeting the menin-mixed lineage leukaemia interface.发现两种氨基糖苷类抗生素作为靶向 menin-混合谱系白血病界面的抑制剂。
Bioorg Med Chem Lett. 2014 May 1;24(9):2090-3. doi: 10.1016/j.bmcl.2014.03.055. Epub 2014 Mar 26.
5
Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction.靶向Menin-混合谱系白血病相互作用的抑制剂设计
Computation (Basel). 2024 Jan;12(1). doi: 10.3390/computation12010003. Epub 2023 Dec 27.
6
Identification of novel small-molecule inhibitors targeting menin-MLL interaction, repurposing the antidiarrheal loperamide.鉴定靶向Menin-MLL相互作用的新型小分子抑制剂,重新利用止泻药洛哌丁胺。
Org Biomol Chem. 2016 Sep 28;14(36):8503-19. doi: 10.1039/c6ob01248e. Epub 2016 Aug 19.
7
Application of a simple quantum chemical approach to ligand fragment scoring for Trypanosoma brucei pteridine reductase 1 inhibition.一种简单的量子化学方法在布氏锥虫蝶啶还原酶1抑制的配体片段评分中的应用。
J Comput Aided Mol Des. 2017 Aug;31(8):715-728. doi: 10.1007/s10822-017-0035-4. Epub 2017 Jul 7.
8
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.组蛋白去乙酰化酶和 MLL- menin 相互作用的双重抑制通过破坏 DNA 损伤检查点和修复来靶向 MLL 重排的急性髓系白血病细胞。
Clin Epigenetics. 2019 Oct 7;11(1):137. doi: 10.1186/s13148-019-0723-0.
9
Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) InteractionMenin与混合谱系白血病(MLL)相互作用的抑制剂
10
Discovery of Novel Inhibitors Targeting the Menin-Mixed Lineage Leukemia Interface Using Pharmacophore- and Docking-Based Virtual Screening.基于药效团和对接的虚拟筛选发现靶向 Menin-Mixed Lineage Leukemia 界面的新型抑制剂。
J Chem Inf Model. 2016 Sep 26;56(9):1847-55. doi: 10.1021/acs.jcim.6b00185. Epub 2016 Aug 24.

引用本文的文献

1
Extension of an Atom-Atom Dispersion Function to Halogen Bonds and Its Use for Rational Design of Drugs and Biocatalysts.原子-原子色散函数向卤键的扩展及其在药物和生物催化剂合理设计中的应用。
J Phys Chem A. 2021 Mar 4;125(8):1787-1799. doi: 10.1021/acs.jpca.0c11347. Epub 2021 Feb 23.
2
Revisiting the halogen bonding between phosphodiesterase type 5 and its inhibitors.重新审视5型磷酸二酯酶与其抑制剂之间的卤键作用。
J Mol Model. 2019 Jan 7;25(2):29. doi: 10.1007/s00894-018-3897-z.
3
Theoretical Model of EphA2-Ephrin A1 Inhibition.EphA2-Ephrin A1 抑制的理论模型。

本文引用的文献

1
Ligand-Binding Affinity Estimates Supported by Quantum-Mechanical Methods.基于量子力学方法的配体结合亲和力估算。
Chem Rev. 2016 May 11;116(9):5520-66. doi: 10.1021/acs.chemrev.5b00630. Epub 2016 Apr 14.
2
Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL).基于结构的针对Menin与混合谱系白血病(MLL)蛋白-蛋白相互作用的小分子抑制剂的性质导向优化
J Med Chem. 2016 Feb 11;59(3):892-913. doi: 10.1021/acs.jmedchem.5b01305. Epub 2016 Jan 25.
3
Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA Calculation.
Molecules. 2018 Jul 11;23(7):1688. doi: 10.3390/molecules23071688.
通过可极化分子动力学模拟和量子力学/分子力学广义玻恩表面面积计算探究抑制剂与MDM2和MDMX结合差异的起源
Sci Rep. 2015 Nov 30;5:17421. doi: 10.1038/srep17421.
4
Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values.经验计算和pKa值合理化中配体及偶联效应的改进处理
J Chem Theory Comput. 2011 Jul 12;7(7):2284-95. doi: 10.1021/ct200133y. Epub 2011 Jun 9.
5
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions.PROPKA3:经验 pKa 预测中内部残基和表面残基的一致处理。
J Chem Theory Comput. 2011 Feb 8;7(2):525-37. doi: 10.1021/ct100578z. Epub 2011 Jan 6.
6
Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes.蛋白质-配体复合物中与氟形成正交多极相互作用的合理设计。
J Med Chem. 2015 Sep 24;58(18):7465-74. doi: 10.1021/acs.jmedchem.5b00975. Epub 2015 Sep 6.
7
Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions.在开发靶向蛋白质-蛋白质相互作用的抑制剂过程中克服化学、生物学和计算方面的挑战。
Chem Biol. 2015 Jun 18;22(6):689-703. doi: 10.1016/j.chembiol.2015.04.019.
8
Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.对Menin-MLL相互作用的药理学抑制可阻断MLL白血病在体内的进展。
Cancer Cell. 2015 Apr 13;27(4):589-602. doi: 10.1016/j.ccell.2015.02.016. Epub 2015 Mar 26.
9
Computational analysis of spiro-oxindole inhibitors of the MDM2-p53 interaction: insights and selection of novel inhibitors.MDM2-p53相互作用的螺环氧化吲哚抑制剂的计算分析:新抑制剂的见解与筛选
J Biomol Struct Dyn. 2016;34(2):341-51. doi: 10.1080/07391102.2015.1031178. Epub 2015 Jun 23.
10
In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.低分子量蛋白质-蛋白质相互作用抑制剂的计算机辅助设计:总体概念与最新进展
Prog Biophys Mol Biol. 2015 Oct;119(1):20-32. doi: 10.1016/j.pbiomolbio.2015.02.006. Epub 2015 Mar 5.